Pancreatitis and Hyperlipasemia in the Setting of Immune Checkpoint Inhibitor Therapy.

Saved in:
Bibliographic Details
Title: Pancreatitis and Hyperlipasemia in the Setting of Immune Checkpoint Inhibitor Therapy.
Authors: Townsend MJ; Department of Medicine, Duke University Medical Center, Durham, North Carolina., Liu M; Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Giobbie-Hurder A; Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Sack JS; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., LeBoeuf NR; Harvard Medical School, Boston, Massachusetts.; Department of Dermatology, Center for Cutaneous Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts., Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., McNabb-Baltar J; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Grover S; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Source: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2023 Aug; Vol. 21 (8), pp. 831-840.e3.
Publication Type: Journal Article
Journal Info: Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Print Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1540-1413
DOI:10.6004/jnccn.2023.7034